Euphoria - References

References:

1. Seevers MH, Pfeiffer CC. A study of the analgesia, subjective depression, and euphoria produced by morphine, heroine, dilaudid, and codeine in the normal human subject. J Pharmacol Exp Ther. 1936; 56(2): 166-87.
2. Cathelin M, Vignes R, Malki A, Viars P. Comparison between the side-effects of fentanyl and morphine in conscious man. Anesth Analg (Paris) 1980; 37(5-6): 265-73.
3. Salimpoor VN, Benovoy M, Larcher K, Dagher A, Zatorre RJ. Anatomically distinct dopamine release during anticipation and experience of peak emotion to music. Nat Neurosci. 2011; 14 (2): 257-62. doi:10.1038/nn.2726; PMID 21217764.
4. Bearn J, O’Brien M. “Addicted to Euphoria”: The history, clinical presentation, and management of party drug misuse. Int Rev Neurobiol. 2015; 120: 205-33. doi: 10.1016/bs.irn.2015.02.005; PMID 26070759.
5. Schaefer CP, Tome ME, Davis TP. The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse. Fluids Barriers CNS. 2017; 14(1): 32. doi: 10.1186/s12987-017-0080-3; PMID: 29183383.
6. Calderon SN, Hunt J, Klein M. A regulatory perspective on the evaluation of hallucinogen drugs for human use. Neuropharmacology. 2017 Nov 24. pii: S0028-3908(17)30537-3. doi: 10.1016/j.neuropharm.2017.11.028; PMID: 29180224.
7. Ikemoto S, Yang C, Tan A. Basal ganglia circuit loops, dopamine, and motivation: A review and enquiry. Behav Brain Res. 2015 Sep 1; 290: 17-31. doi: 10.1016/j.bbr.2015.04.018; PMID: 25907747.
8. Koob GF. The dark side of emotion: the addiction perspective. Eur J Pharmacol. 2015 Apr 15; 753: 73-87. doi: 10.1016/j.ejphar.2014.11.044; PMID: 25583178.
9. Wood S, Sage JR, Shuman T, Anagnostaras SG. Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev. 2013 Dec 16; 66(1): 193-221. doi: 10.1124/pr.112.007054; PMID: 24344115.

Author: Dr. Kaushik Bharati

Editor: Dr. Lakshmi Venkataraman

Technically Checked by: Lingaraj